PL3668856T3 - Nowe związki tetrazolu i ich zastosowanie w leczeniu gruźlicy - Google Patents
Nowe związki tetrazolu i ich zastosowanie w leczeniu gruźlicyInfo
- Publication number
- PL3668856T3 PL3668856T3 PL18755815T PL18755815T PL3668856T3 PL 3668856 T3 PL3668856 T3 PL 3668856T3 PL 18755815 T PL18755815 T PL 18755815T PL 18755815 T PL18755815 T PL 18755815T PL 3668856 T3 PL3668856 T3 PL 3668856T3
- Authority
- PL
- Poland
- Prior art keywords
- tuberculosis
- treatment
- tetrazole compounds
- novel tetrazole
- novel
- Prior art date
Links
- -1 tetrazole compounds Chemical class 0.000 title 1
- 201000008827 tuberculosis Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17382574 | 2017-08-17 | ||
| PCT/EP2018/072205 WO2019034729A1 (en) | 2017-08-17 | 2018-08-16 | NOVEL TETRAZOLE COMPOUNDS AND THEIR USE IN THE TREATMENT OF TUBERCULOSIS |
| EP18755815.0A EP3668856B1 (en) | 2017-08-17 | 2018-08-16 | Novel tetrazole compounds and their use in the treatment of tuberculosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3668856T3 true PL3668856T3 (pl) | 2021-12-13 |
Family
ID=59713960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18755815T PL3668856T3 (pl) | 2017-08-17 | 2018-08-16 | Nowe związki tetrazolu i ich zastosowanie w leczeniu gruźlicy |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US11072591B2 (pl) |
| EP (1) | EP3668856B1 (pl) |
| JP (1) | JP7410017B2 (pl) |
| KR (1) | KR102661367B1 (pl) |
| CN (1) | CN110997651B (pl) |
| AU (1) | AU2018317812C1 (pl) |
| CA (1) | CA3072854A1 (pl) |
| CY (1) | CY1124577T1 (pl) |
| DK (1) | DK3668856T3 (pl) |
| ES (1) | ES2885573T3 (pl) |
| HR (1) | HRP20211326T1 (pl) |
| HU (1) | HUE055732T2 (pl) |
| LT (1) | LT3668856T (pl) |
| PL (1) | PL3668856T3 (pl) |
| PT (1) | PT3668856T (pl) |
| RS (1) | RS62267B1 (pl) |
| SI (1) | SI3668856T1 (pl) |
| SM (1) | SMT202100515T1 (pl) |
| WO (1) | WO2019034729A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111184718A (zh) * | 2018-11-15 | 2020-05-22 | 鲁南制药集团股份有限公司 | 法罗培南在制备治疗初治病原学阳性肺结核药物中的用途 |
| CN115403533B (zh) * | 2021-05-28 | 2023-08-25 | 永康市第一人民医院 | 一种1-苯乙烯基-1,2,3-三氮唑化合物及其制备方法和应用 |
| CN116102483B (zh) * | 2021-11-09 | 2025-01-17 | 中国医学科学院药物研究所 | 取代吡咯-2,5-二酮类化合物及其制备方法和用途 |
| CN116726018A (zh) * | 2023-08-02 | 2023-09-12 | 上海市肺科医院（上海市职业病防治院） | 一种贝达喹啉、德拉马尼、氯法齐明和吡嗪酰胺的联用和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1029541B1 (en) * | 1997-07-22 | 2006-03-22 | Shionogi & Co., Ltd. | Therapeutic or prophylactic agent for glomerulopathy |
| WO2008124703A2 (en) * | 2007-04-05 | 2008-10-16 | Siemens Medical Solutions Usa, Inc. | Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry |
| WO2017066964A1 (en) | 2015-10-22 | 2017-04-27 | Merck Sharp & Dohme Corp. | Oxazolidinone compounds and methods of use thereof as antibacterial agents |
-
2018
- 2018-08-16 PL PL18755815T patent/PL3668856T3/pl unknown
- 2018-08-16 WO PCT/EP2018/072205 patent/WO2019034729A1/en not_active Ceased
- 2018-08-16 ES ES18755815T patent/ES2885573T3/es active Active
- 2018-08-16 RS RS20211076A patent/RS62267B1/sr unknown
- 2018-08-16 HU HUE18755815A patent/HUE055732T2/hu unknown
- 2018-08-16 KR KR1020207007186A patent/KR102661367B1/ko active Active
- 2018-08-16 PT PT187558150T patent/PT3668856T/pt unknown
- 2018-08-16 HR HRP20211326TT patent/HRP20211326T1/hr unknown
- 2018-08-16 JP JP2020508427A patent/JP7410017B2/ja active Active
- 2018-08-16 LT LTEPPCT/EP2018/072205T patent/LT3668856T/lt unknown
- 2018-08-16 CA CA3072854A patent/CA3072854A1/en active Pending
- 2018-08-16 CN CN201880053320.XA patent/CN110997651B/zh active Active
- 2018-08-16 DK DK18755815.0T patent/DK3668856T3/da active
- 2018-08-16 AU AU2018317812A patent/AU2018317812C1/en active Active
- 2018-08-16 US US16/639,163 patent/US11072591B2/en active Active
- 2018-08-16 SM SM20210515T patent/SMT202100515T1/it unknown
- 2018-08-16 SI SI201830348T patent/SI3668856T1/sl unknown
- 2018-08-16 EP EP18755815.0A patent/EP3668856B1/en active Active
-
2021
- 2021-08-31 CY CY20211100770T patent/CY1124577T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019034729A1 (en) | 2019-02-21 |
| EP3668856B1 (en) | 2021-06-23 |
| LT3668856T (lt) | 2021-09-27 |
| HRP20211326T1 (hr) | 2021-11-26 |
| AU2018317812C1 (en) | 2021-08-26 |
| ES2885573T3 (es) | 2021-12-14 |
| CN110997651A (zh) | 2020-04-10 |
| AU2018317812A1 (en) | 2020-02-20 |
| HUE055732T2 (hu) | 2021-12-28 |
| RS62267B1 (sr) | 2021-09-30 |
| SMT202100515T1 (it) | 2021-11-12 |
| BR112020003247A2 (pt) | 2020-08-18 |
| DK3668856T3 (da) | 2021-09-20 |
| EP3668856A1 (en) | 2020-06-24 |
| AU2018317812B2 (en) | 2021-04-15 |
| US11072591B2 (en) | 2021-07-27 |
| RU2020110818A3 (pl) | 2021-10-11 |
| CN110997651B (zh) | 2023-01-03 |
| CA3072854A1 (en) | 2019-02-21 |
| JP2020531425A (ja) | 2020-11-05 |
| KR102661367B1 (ko) | 2024-04-29 |
| SI3668856T1 (sl) | 2021-11-30 |
| CY1124577T1 (el) | 2022-07-22 |
| PT3668856T (pt) | 2021-09-15 |
| KR20200041915A (ko) | 2020-04-22 |
| RU2020110818A (ru) | 2021-09-17 |
| JP7410017B2 (ja) | 2024-01-09 |
| US20200231555A1 (en) | 2020-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201411496D0 (en) | Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy | |
| PT3362448T (pt) | Novos compostos inibidores da interação yap/taz-tead e sua utilização no tratamento do mesotelioma maligno | |
| SI4014976T1 (sl) | Aprocitentan za uporabo pri zdravljenju hipertenzije in sorodnih bolezni v kombinaciji z valsartanom | |
| PL3554522T3 (pl) | Probiotyki do stosowania w leczeniu uchyłkowatości i chorobyuchyłkowej | |
| GB201511382D0 (en) | Novel compounds and their use in therapy | |
| IL284053A (en) | New compounds and their use in therapy | |
| IL250484B (en) | Heterovesicular compounds and their use in the treatment of tuberculosis | |
| GB201715194D0 (en) | Compounds and their therapeutic use | |
| ZA201704726B (en) | Peptides and their use in the treatment of skin | |
| GB201617064D0 (en) | Compounds and their therapeutic use | |
| SI3331610T1 (sl) | Sredstva za uporabo pri zdravljenju gliomov | |
| PT3668856T (pt) | Novos compostos de tetrazole e sua utilização no tratamento de tuberculose | |
| GB201415063D0 (en) | A therapeutic agent for use in the treatment of infections | |
| ZA201905402B (en) | Compounds and their use in the treatment of schistosomiasis | |
| ZA202006886B (en) | R-fadrozole for use in the treatment of aldostonerism | |
| IL273863A (en) | Hemorrhoid treatment device | |
| IL253418A0 (en) | Nisin-based compounds and their use in the treatment of bacterial infections | |
| AU2016905362A0 (en) | Compounds and use thereof in methods of treatment |